Food & Beverages
Global OPO-containing Infant Formulas Market Research Report 2026
- Feb 24, 26
- ID: 716419
- Pages: 125
- Figures: 121
- Views: 1
This report delivers a comprehensive overview of the global OPO-containing Infant Formulas market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding OPO-containing Infant Formulas. The OPO-containing Infant Formulas market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global OPO-containing Infant Formulas market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist OPO-containing Infant Formulas manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
Segment by Type
Cow Milk Formula
Goat Milk Formula
by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for OPO-containing Infant Formulas manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines OPO-containing Infant Formulas sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global OPO-containing Infant Formulas market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist OPO-containing Infant Formulas manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
Segment by Type
Cow Milk Formula
Goat Milk Formula
by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for OPO-containing Infant Formulas manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines OPO-containing Infant Formulas sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 OPO-containing Infant Formulas Market Overview
1.1 Product Definition
1.2 OPO-containing Infant Formulas by Type
1.2.1 Global OPO-containing Infant Formulas Market Value by Type: 2025 vs 2032
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO-containing Infant Formulas by Application
1.3.1 Global OPO-containing Infant Formulas Market Value by Application: 2025 vs 2032
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO-containing Infant Formulas Market Size Estimates and Forecasts
1.4.1 Global OPO-containing Infant Formulas Revenue 2021–2032
1.4.2 Global OPO-containing Infant Formulas Sales 2021–2032
1.4.3 Global OPO-containing Infant Formulas Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 OPO-containing Infant Formulas Market Competition by Manufacturers
2.1 Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
2.2 Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2021–2026)
2.3 Global OPO-containing Infant Formulas Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
2.7 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
2.8 Global OPO-containing Infant Formulas Market Competitive Situation and Trends
2.8.1 Global OPO-containing Infant Formulas Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global OPO-containing Infant Formulas Players Market Share by Revenue
2.8.3 Global OPO-containing Infant Formulas Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OPO-containing Infant Formulas Market Scenario by Region
3.1 Global OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global OPO-containing Infant Formulas Sales by Region: 2021–2032
3.2.1 Global OPO-containing Infant Formulas Sales by Region: 2021–2026
3.2.2 Global OPO-containing Infant Formulas Sales by Region: 2027–2032
3.3 Global OPO-containing Infant Formulas Revenue by Region: 2021–2032
3.3.1 Global OPO-containing Infant Formulas Revenue by Region: 2021–2026
3.3.2 Global OPO-containing Infant Formulas Revenue by Region: 2027–2032
3.4 North America OPO-containing Infant Formulas Market Facts & Figures by Country
3.4.1 North America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.4.3 North America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OPO-containing Infant Formulas Market Facts & Figures by Country
3.5.1 Europe OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe OPO-containing Infant Formulas Sales by Country (2021–2032)
3.5.3 Europe OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPO-containing Infant Formulas Market Facts & Figures by Region
3.6.1 Asia Pacific OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific OPO-containing Infant Formulas Sales by Region (2021–2032)
3.6.3 Asia Pacific OPO-containing Infant Formulas Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.6.10 Vietnam
3.7 Latin America OPO-containing Infant Formulas Market Facts & Figures by Country
3.7.1 Latin America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.7.3 Latin America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPO-containing Infant Formulas Market Facts & Figures by Country
3.8.1 Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021–2032)
3.8.3 Middle East and Africa OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OPO-containing Infant Formulas Sales by Type (2021–2032)
4.1.1 Global OPO-containing Infant Formulas Sales by Type (2021–2026)
4.1.2 Global OPO-containing Infant Formulas Sales by Type (2027–2032)
4.1.3 Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2032)
4.2 Global OPO-containing Infant Formulas Revenue by Type (2021–2032)
4.2.1 Global OPO-containing Infant Formulas Revenue by Type (2021–2026)
4.2.2 Global OPO-containing Infant Formulas Revenue by Type (2027–2032)
4.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2032)
4.3 Global OPO-containing Infant Formulas Price by Type (2021–2032)
5 Segment by Application
5.1 Global OPO-containing Infant Formulas Sales by Application (2021–2032)
5.1.1 Global OPO-containing Infant Formulas Sales by Application (2021–2026)
5.1.2 Global OPO-containing Infant Formulas Sales by Application (2027–2032)
5.1.3 Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2032)
5.2 Global OPO-containing Infant Formulas Revenue by Application (2021–2032)
5.2.1 Global OPO-containing Infant Formulas Revenue by Application (2021–2026)
5.2.2 Global OPO-containing Infant Formulas Revenue by Application (2027–2032)
5.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2032)
5.3 Global OPO-containing Infant Formulas Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BiosTime
6.1.1 BiosTime Company Information
6.1.2 BiosTime Description and Business Overview
6.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
6.1.5 BiosTime Recent Developments/Updates
6.2 Nutriben
6.2.1 Nutriben Company Information
6.2.2 Nutriben Description and Business Overview
6.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
6.2.5 Nutriben Recent Developments/Updates
6.3 Ausnutria
6.3.1 Ausnutria Company Information
6.3.2 Ausnutria Description and Business Overview
6.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
6.3.5 Ausnutria Recent Developments/Updates
6.4 HERDS
6.4.1 HERDS Company Information
6.4.2 HERDS Description and Business Overview
6.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
6.4.5 HERDS Recent Developments/Updates
6.5 Milupa
6.5.1 Milupa Company Information
6.5.2 Milupa Description and Business Overview
6.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
6.5.5 Milupa Recent Developments/Updates
6.6 Shanxi Yatai
6.6.1 Shanxi Yatai Company Information
6.6.2 Shanxi Yatai Description and Business Overview
6.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
6.6.5 Shanxi Yatai Recent Developments/Updates
6.7 Beingmate
6.7.1 Beingmate Company Information
6.7.2 Beingmate Description and Business Overview
6.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
6.7.5 Beingmate Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Brightdairy
6.9.1 Brightdairy Company Information
6.9.2 Brightdairy Description and Business Overview
6.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
6.9.5 Brightdairy Recent Developments/Updates
6.10 Feihe
6.10.1 Feihe Company Information
6.10.2 Feihe Description and Business Overview
6.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
6.10.5 Feihe Recent Developments/Updates
6.11 Wyeth Nutrition
6.11.1 Wyeth Nutrition Company Information
6.11.2 Wyeth Nutrition Description and Business Overview
6.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
6.11.5 Wyeth Nutrition Recent Developments/Updates
6.12 Deloraine
6.12.1 Deloraine Company Information
6.12.2 Deloraine Description and Business Overview
6.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
6.12.5 Deloraine Recent Developments/Updates
6.13 Yili
6.13.1 Yili Company Information
6.13.2 Yili Description and Business Overview
6.13.3 Yili OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yili OPO-containing Infant Formulas Product Portfolio
6.13.5 Yili Recent Developments/Updates
6.14 Kabrita
6.14.1 Kabrita Company Information
6.14.2 Kabrita Description and Business Overview
6.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
6.14.5 Kabrita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPO-containing Infant Formulas Industry Chain Analysis
7.2 OPO-containing Infant Formulas Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPO-containing Infant Formulas Production Mode & Process Analysis
7.4 OPO-containing Infant Formulas Sales and Marketing
7.4.1 OPO-containing Infant Formulas Sales Channels
7.4.2 OPO-containing Infant Formulas Distributors
7.5 OPO-containing Infant Formulas Customer Analysis
8 OPO-containing Infant Formulas Market Dynamics
8.1 OPO-containing Infant Formulas Industry Trends
8.2 OPO-containing Infant Formulas Market Drivers
8.3 OPO-containing Infant Formulas Market Challenges
8.4 OPO-containing Infant Formulas Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 OPO-containing Infant Formulas by Type
1.2.1 Global OPO-containing Infant Formulas Market Value by Type: 2025 vs 2032
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO-containing Infant Formulas by Application
1.3.1 Global OPO-containing Infant Formulas Market Value by Application: 2025 vs 2032
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO-containing Infant Formulas Market Size Estimates and Forecasts
1.4.1 Global OPO-containing Infant Formulas Revenue 2021–2032
1.4.2 Global OPO-containing Infant Formulas Sales 2021–2032
1.4.3 Global OPO-containing Infant Formulas Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 OPO-containing Infant Formulas Market Competition by Manufacturers
2.1 Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
2.2 Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2021–2026)
2.3 Global OPO-containing Infant Formulas Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
2.7 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
2.8 Global OPO-containing Infant Formulas Market Competitive Situation and Trends
2.8.1 Global OPO-containing Infant Formulas Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global OPO-containing Infant Formulas Players Market Share by Revenue
2.8.3 Global OPO-containing Infant Formulas Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OPO-containing Infant Formulas Market Scenario by Region
3.1 Global OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global OPO-containing Infant Formulas Sales by Region: 2021–2032
3.2.1 Global OPO-containing Infant Formulas Sales by Region: 2021–2026
3.2.2 Global OPO-containing Infant Formulas Sales by Region: 2027–2032
3.3 Global OPO-containing Infant Formulas Revenue by Region: 2021–2032
3.3.1 Global OPO-containing Infant Formulas Revenue by Region: 2021–2026
3.3.2 Global OPO-containing Infant Formulas Revenue by Region: 2027–2032
3.4 North America OPO-containing Infant Formulas Market Facts & Figures by Country
3.4.1 North America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.4.3 North America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OPO-containing Infant Formulas Market Facts & Figures by Country
3.5.1 Europe OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe OPO-containing Infant Formulas Sales by Country (2021–2032)
3.5.3 Europe OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPO-containing Infant Formulas Market Facts & Figures by Region
3.6.1 Asia Pacific OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific OPO-containing Infant Formulas Sales by Region (2021–2032)
3.6.3 Asia Pacific OPO-containing Infant Formulas Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.6.10 Vietnam
3.7 Latin America OPO-containing Infant Formulas Market Facts & Figures by Country
3.7.1 Latin America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.7.3 Latin America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPO-containing Infant Formulas Market Facts & Figures by Country
3.8.1 Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021–2032)
3.8.3 Middle East and Africa OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OPO-containing Infant Formulas Sales by Type (2021–2032)
4.1.1 Global OPO-containing Infant Formulas Sales by Type (2021–2026)
4.1.2 Global OPO-containing Infant Formulas Sales by Type (2027–2032)
4.1.3 Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2032)
4.2 Global OPO-containing Infant Formulas Revenue by Type (2021–2032)
4.2.1 Global OPO-containing Infant Formulas Revenue by Type (2021–2026)
4.2.2 Global OPO-containing Infant Formulas Revenue by Type (2027–2032)
4.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2032)
4.3 Global OPO-containing Infant Formulas Price by Type (2021–2032)
5 Segment by Application
5.1 Global OPO-containing Infant Formulas Sales by Application (2021–2032)
5.1.1 Global OPO-containing Infant Formulas Sales by Application (2021–2026)
5.1.2 Global OPO-containing Infant Formulas Sales by Application (2027–2032)
5.1.3 Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2032)
5.2 Global OPO-containing Infant Formulas Revenue by Application (2021–2032)
5.2.1 Global OPO-containing Infant Formulas Revenue by Application (2021–2026)
5.2.2 Global OPO-containing Infant Formulas Revenue by Application (2027–2032)
5.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2032)
5.3 Global OPO-containing Infant Formulas Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BiosTime
6.1.1 BiosTime Company Information
6.1.2 BiosTime Description and Business Overview
6.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
6.1.5 BiosTime Recent Developments/Updates
6.2 Nutriben
6.2.1 Nutriben Company Information
6.2.2 Nutriben Description and Business Overview
6.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
6.2.5 Nutriben Recent Developments/Updates
6.3 Ausnutria
6.3.1 Ausnutria Company Information
6.3.2 Ausnutria Description and Business Overview
6.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
6.3.5 Ausnutria Recent Developments/Updates
6.4 HERDS
6.4.1 HERDS Company Information
6.4.2 HERDS Description and Business Overview
6.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
6.4.5 HERDS Recent Developments/Updates
6.5 Milupa
6.5.1 Milupa Company Information
6.5.2 Milupa Description and Business Overview
6.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
6.5.5 Milupa Recent Developments/Updates
6.6 Shanxi Yatai
6.6.1 Shanxi Yatai Company Information
6.6.2 Shanxi Yatai Description and Business Overview
6.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
6.6.5 Shanxi Yatai Recent Developments/Updates
6.7 Beingmate
6.7.1 Beingmate Company Information
6.7.2 Beingmate Description and Business Overview
6.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
6.7.5 Beingmate Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Brightdairy
6.9.1 Brightdairy Company Information
6.9.2 Brightdairy Description and Business Overview
6.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
6.9.5 Brightdairy Recent Developments/Updates
6.10 Feihe
6.10.1 Feihe Company Information
6.10.2 Feihe Description and Business Overview
6.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
6.10.5 Feihe Recent Developments/Updates
6.11 Wyeth Nutrition
6.11.1 Wyeth Nutrition Company Information
6.11.2 Wyeth Nutrition Description and Business Overview
6.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
6.11.5 Wyeth Nutrition Recent Developments/Updates
6.12 Deloraine
6.12.1 Deloraine Company Information
6.12.2 Deloraine Description and Business Overview
6.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
6.12.5 Deloraine Recent Developments/Updates
6.13 Yili
6.13.1 Yili Company Information
6.13.2 Yili Description and Business Overview
6.13.3 Yili OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yili OPO-containing Infant Formulas Product Portfolio
6.13.5 Yili Recent Developments/Updates
6.14 Kabrita
6.14.1 Kabrita Company Information
6.14.2 Kabrita Description and Business Overview
6.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
6.14.5 Kabrita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPO-containing Infant Formulas Industry Chain Analysis
7.2 OPO-containing Infant Formulas Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPO-containing Infant Formulas Production Mode & Process Analysis
7.4 OPO-containing Infant Formulas Sales and Marketing
7.4.1 OPO-containing Infant Formulas Sales Channels
7.4.2 OPO-containing Infant Formulas Distributors
7.5 OPO-containing Infant Formulas Customer Analysis
8 OPO-containing Infant Formulas Market Dynamics
8.1 OPO-containing Infant Formulas Industry Trends
8.2 OPO-containing Infant Formulas Market Drivers
8.3 OPO-containing Infant Formulas Market Challenges
8.4 OPO-containing Infant Formulas Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global OPO-containing Infant Formulas Market Competitive Situation by Manufacturers in 2025
Table 4. Global OPO-containing Infant Formulas Sales (K MT) of Key Manufacturers (2021–2026)
Table 5. Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
Table 6. Global OPO-containing Infant Formulas Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global OPO-containing Infant Formulas Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market OPO-containing Infant Formulas Average Price (USD/MT) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
Table 12. Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OPO-containing Infant Formulas Companies by Tier (Tier 1, Tier 2, Tier 3), based on OPO-containing Infant Formulas Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
Table 18. Global OPO-containing Infant Formulas Sales Market Share by Region (2021–2026)
Table 19. Global OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
Table 20. Global OPO-containing Infant Formulas Sales Market Share by Region (2027–2032)
Table 21. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
Table 22. Global OPO-containing Infant Formulas Revenue Market Share by Region (2021–2026)
Table 23. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
Table 24. Global OPO-containing Infant Formulas Revenue Market Share by Region (2027–2032)
Table 25. North America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 27. North America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 28. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 29. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 30. Europe OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 32. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 33. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 34. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific OPO-containing Infant Formulas Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
Table 37. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
Table 38. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 42. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 43. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 47. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 48. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 50. Global OPO-containing Infant Formulas Sales (K MT) by Type (2021–2026)
Table 51. Global OPO-containing Infant Formulas Sales (K MT) by Type (2027–2032)
Table 52. Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2026)
Table 53. Global OPO-containing Infant Formulas Sales Market Share by Type (2027–2032)
Table 54. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2021–2026)
Table 55. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2027–2032)
Table 56. Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2026)
Table 57. Global OPO-containing Infant Formulas Revenue Market Share by Type (2027–2032)
Table 58. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2026)
Table 59. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2027–2032)
Table 60. Global OPO-containing Infant Formulas Sales (K MT) by Application (2021–2026)
Table 61. Global OPO-containing Infant Formulas Sales (K MT) by Application (2027–2032)
Table 62. Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2026)
Table 63. Global OPO-containing Infant Formulas Sales Market Share by Application (2027–2032)
Table 64. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2021–2026)
Table 65. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2027–2032)
Table 66. Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2026)
Table 67. Global OPO-containing Infant Formulas Revenue Market Share by Application (2027–2032)
Table 68. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2026)
Table 69. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2027–2032)
Table 70. BiosTime Company Information
Table 71. BiosTime Description and Business Overview
Table 72. BiosTime OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 73. BiosTime OPO-containing Infant Formulas Product
Table 74. BiosTime Recent Developments/Updates
Table 75. Nutriben Company Information
Table 76. Nutriben Description and Business Overview
Table 77. Nutriben OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 78. Nutriben OPO-containing Infant Formulas Product
Table 79. Nutriben Recent Developments/Updates
Table 80. Ausnutria Company Information
Table 81. Ausnutria Description and Business Overview
Table 82. Ausnutria OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 83. Ausnutria OPO-containing Infant Formulas Product
Table 84. Ausnutria Recent Developments/Updates
Table 85. HERDS Company Information
Table 86. HERDS Description and Business Overview
Table 87. HERDS OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 88. HERDS OPO-containing Infant Formulas Product
Table 89. HERDS Recent Developments/Updates
Table 90. Milupa Company Information
Table 91. Milupa Description and Business Overview
Table 92. Milupa OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 93. Milupa OPO-containing Infant Formulas Product
Table 94. Milupa Recent Developments/Updates
Table 95. Shanxi Yatai Company Information
Table 96. Shanxi Yatai Description and Business Overview
Table 97. Shanxi Yatai OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 98. Shanxi Yatai OPO-containing Infant Formulas Product
Table 99. Shanxi Yatai Recent Developments/Updates
Table 100. Beingmate Company Information
Table 101. Beingmate Description and Business Overview
Table 102. Beingmate OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 103. Beingmate OPO-containing Infant Formulas Product
Table 104. Beingmate Recent Developments/Updates
Table 105. Abbott Company Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 108. Abbott OPO-containing Infant Formulas Product
Table 109. Abbott Recent Developments/Updates
Table 110. Brightdairy Company Information
Table 111. Brightdairy Description and Business Overview
Table 112. Brightdairy OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 113. Brightdairy OPO-containing Infant Formulas Product
Table 114. Brightdairy Recent Developments/Updates
Table 115. Feihe Company Information
Table 116. Feihe Description and Business Overview
Table 117. Feihe OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 118. Feihe OPO-containing Infant Formulas Product
Table 119. Feihe Recent Developments/Updates
Table 120. Wyeth Nutrition Company Information
Table 121. Wyeth Nutrition Description and Business Overview
Table 122. Wyeth Nutrition OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 123. Wyeth Nutrition OPO-containing Infant Formulas Product
Table 124. Wyeth Nutrition Recent Developments/Updates
Table 125. Deloraine Company Information
Table 126. Deloraine Description and Business Overview
Table 127. Deloraine OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 128. Deloraine OPO-containing Infant Formulas Product
Table 129. Deloraine Recent Developments/Updates
Table 130. Yili Company Information
Table 131. Yili Description and Business Overview
Table 132. Yili OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 133. Yili OPO-containing Infant Formulas Product
Table 134. Yili Recent Developments/Updates
Table 135. Kabrita Company Information
Table 136. Kabrita Description and Business Overview
Table 137. Kabrita OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 138. Kabrita OPO-containing Infant Formulas Product
Table 139. Kabrita Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. OPO-containing Infant Formulas Distributors List
Table 143. OPO-containing Infant Formulas Customers List
Table 144. OPO-containing Infant Formulas Market Trends
Table 145. OPO-containing Infant Formulas Market Drivers
Table 146. OPO-containing Infant Formulas Market Challenges
Table 147. OPO-containing Infant Formulas Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of OPO-containing Infant Formulas
Figure 2. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2021–2032
Figure 3. Global OPO-containing Infant Formulas Market Share by Type: 2025 & 2032
Figure 4. Cow Milk Formula Product Picture
Figure 5. Goat Milk Formula Product Picture
Figure 6. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2021–2032
Figure 7. Global OPO-containing Infant Formulas Market Share by Application: 2025 & 2032
Figure 8. 0 - 6 Month
Figure 9. 6 - 12 Month
Figure 10. 12 - 36 Month
Figure 11. Global OPO-containing Infant Formulas Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global OPO-containing Infant Formulas Market Size (US$ Million), 2021–2032
Figure 13. Global OPO-containing Infant Formulas Sales (K MT), 2021–2032
Figure 14. Global OPO-containing Infant Formulas Average Price (USD/MT), 2021–2032
Figure 15. OPO-containing Infant Formulas Report Years Considered
Figure 16. OPO-containing Infant Formulas Sales Share by Manufacturers in 2025
Figure 17. Global OPO-containing Infant Formulas Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global OPO-containing Infant Formulas Players: Market Share by Revenue in OPO-containing Infant Formulas in 2025
Figure 19. OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 22. North America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 23. U.S. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 26. Europe OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 27. Germany OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific OPO-containing Infant Formulas Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific OPO-containing Infant Formulas Revenue Market Share by Region (2021–2032)
Figure 34. China OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Vietnam OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 42. Latin America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 43. Mexico OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 48. Turkey OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. U.A.E OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of OPO-containing Infant Formulas by Type (2021–2032)
Figure 52. Global Revenue Market Share of OPO-containing Infant Formulas by Type (2021–2032)
Figure 53. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2032)
Figure 54. Global Sales Market Share of OPO-containing Infant Formulas by Application (2021–2032)
Figure 55. Global Revenue Market Share of OPO-containing Infant Formulas by Application (2021–2032)
Figure 56. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2032)
Figure 57. OPO-containing Infant Formulas Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global OPO-containing Infant Formulas Market Competitive Situation by Manufacturers in 2025
Table 4. Global OPO-containing Infant Formulas Sales (K MT) of Key Manufacturers (2021–2026)
Table 5. Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
Table 6. Global OPO-containing Infant Formulas Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global OPO-containing Infant Formulas Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market OPO-containing Infant Formulas Average Price (USD/MT) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
Table 12. Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OPO-containing Infant Formulas Companies by Tier (Tier 1, Tier 2, Tier 3), based on OPO-containing Infant Formulas Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
Table 18. Global OPO-containing Infant Formulas Sales Market Share by Region (2021–2026)
Table 19. Global OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
Table 20. Global OPO-containing Infant Formulas Sales Market Share by Region (2027–2032)
Table 21. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
Table 22. Global OPO-containing Infant Formulas Revenue Market Share by Region (2021–2026)
Table 23. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
Table 24. Global OPO-containing Infant Formulas Revenue Market Share by Region (2027–2032)
Table 25. North America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 27. North America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 28. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 29. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 30. Europe OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 32. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 33. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 34. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific OPO-containing Infant Formulas Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
Table 37. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
Table 38. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 42. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 43. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
Table 47. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
Table 48. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
Table 50. Global OPO-containing Infant Formulas Sales (K MT) by Type (2021–2026)
Table 51. Global OPO-containing Infant Formulas Sales (K MT) by Type (2027–2032)
Table 52. Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2026)
Table 53. Global OPO-containing Infant Formulas Sales Market Share by Type (2027–2032)
Table 54. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2021–2026)
Table 55. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2027–2032)
Table 56. Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2026)
Table 57. Global OPO-containing Infant Formulas Revenue Market Share by Type (2027–2032)
Table 58. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2026)
Table 59. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2027–2032)
Table 60. Global OPO-containing Infant Formulas Sales (K MT) by Application (2021–2026)
Table 61. Global OPO-containing Infant Formulas Sales (K MT) by Application (2027–2032)
Table 62. Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2026)
Table 63. Global OPO-containing Infant Formulas Sales Market Share by Application (2027–2032)
Table 64. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2021–2026)
Table 65. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2027–2032)
Table 66. Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2026)
Table 67. Global OPO-containing Infant Formulas Revenue Market Share by Application (2027–2032)
Table 68. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2026)
Table 69. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2027–2032)
Table 70. BiosTime Company Information
Table 71. BiosTime Description and Business Overview
Table 72. BiosTime OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 73. BiosTime OPO-containing Infant Formulas Product
Table 74. BiosTime Recent Developments/Updates
Table 75. Nutriben Company Information
Table 76. Nutriben Description and Business Overview
Table 77. Nutriben OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 78. Nutriben OPO-containing Infant Formulas Product
Table 79. Nutriben Recent Developments/Updates
Table 80. Ausnutria Company Information
Table 81. Ausnutria Description and Business Overview
Table 82. Ausnutria OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 83. Ausnutria OPO-containing Infant Formulas Product
Table 84. Ausnutria Recent Developments/Updates
Table 85. HERDS Company Information
Table 86. HERDS Description and Business Overview
Table 87. HERDS OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 88. HERDS OPO-containing Infant Formulas Product
Table 89. HERDS Recent Developments/Updates
Table 90. Milupa Company Information
Table 91. Milupa Description and Business Overview
Table 92. Milupa OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 93. Milupa OPO-containing Infant Formulas Product
Table 94. Milupa Recent Developments/Updates
Table 95. Shanxi Yatai Company Information
Table 96. Shanxi Yatai Description and Business Overview
Table 97. Shanxi Yatai OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 98. Shanxi Yatai OPO-containing Infant Formulas Product
Table 99. Shanxi Yatai Recent Developments/Updates
Table 100. Beingmate Company Information
Table 101. Beingmate Description and Business Overview
Table 102. Beingmate OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 103. Beingmate OPO-containing Infant Formulas Product
Table 104. Beingmate Recent Developments/Updates
Table 105. Abbott Company Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 108. Abbott OPO-containing Infant Formulas Product
Table 109. Abbott Recent Developments/Updates
Table 110. Brightdairy Company Information
Table 111. Brightdairy Description and Business Overview
Table 112. Brightdairy OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 113. Brightdairy OPO-containing Infant Formulas Product
Table 114. Brightdairy Recent Developments/Updates
Table 115. Feihe Company Information
Table 116. Feihe Description and Business Overview
Table 117. Feihe OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 118. Feihe OPO-containing Infant Formulas Product
Table 119. Feihe Recent Developments/Updates
Table 120. Wyeth Nutrition Company Information
Table 121. Wyeth Nutrition Description and Business Overview
Table 122. Wyeth Nutrition OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 123. Wyeth Nutrition OPO-containing Infant Formulas Product
Table 124. Wyeth Nutrition Recent Developments/Updates
Table 125. Deloraine Company Information
Table 126. Deloraine Description and Business Overview
Table 127. Deloraine OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 128. Deloraine OPO-containing Infant Formulas Product
Table 129. Deloraine Recent Developments/Updates
Table 130. Yili Company Information
Table 131. Yili Description and Business Overview
Table 132. Yili OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 133. Yili OPO-containing Infant Formulas Product
Table 134. Yili Recent Developments/Updates
Table 135. Kabrita Company Information
Table 136. Kabrita Description and Business Overview
Table 137. Kabrita OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 138. Kabrita OPO-containing Infant Formulas Product
Table 139. Kabrita Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. OPO-containing Infant Formulas Distributors List
Table 143. OPO-containing Infant Formulas Customers List
Table 144. OPO-containing Infant Formulas Market Trends
Table 145. OPO-containing Infant Formulas Market Drivers
Table 146. OPO-containing Infant Formulas Market Challenges
Table 147. OPO-containing Infant Formulas Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of OPO-containing Infant Formulas
Figure 2. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2021–2032
Figure 3. Global OPO-containing Infant Formulas Market Share by Type: 2025 & 2032
Figure 4. Cow Milk Formula Product Picture
Figure 5. Goat Milk Formula Product Picture
Figure 6. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2021–2032
Figure 7. Global OPO-containing Infant Formulas Market Share by Application: 2025 & 2032
Figure 8. 0 - 6 Month
Figure 9. 6 - 12 Month
Figure 10. 12 - 36 Month
Figure 11. Global OPO-containing Infant Formulas Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global OPO-containing Infant Formulas Market Size (US$ Million), 2021–2032
Figure 13. Global OPO-containing Infant Formulas Sales (K MT), 2021–2032
Figure 14. Global OPO-containing Infant Formulas Average Price (USD/MT), 2021–2032
Figure 15. OPO-containing Infant Formulas Report Years Considered
Figure 16. OPO-containing Infant Formulas Sales Share by Manufacturers in 2025
Figure 17. Global OPO-containing Infant Formulas Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global OPO-containing Infant Formulas Players: Market Share by Revenue in OPO-containing Infant Formulas in 2025
Figure 19. OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 22. North America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 23. U.S. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 26. Europe OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 27. Germany OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific OPO-containing Infant Formulas Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific OPO-containing Infant Formulas Revenue Market Share by Region (2021–2032)
Figure 34. China OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Vietnam OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 42. Latin America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 43. Mexico OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
Figure 48. Turkey OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. U.A.E OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of OPO-containing Infant Formulas by Type (2021–2032)
Figure 52. Global Revenue Market Share of OPO-containing Infant Formulas by Type (2021–2032)
Figure 53. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2032)
Figure 54. Global Sales Market Share of OPO-containing Infant Formulas by Application (2021–2032)
Figure 55. Global Revenue Market Share of OPO-containing Infant Formulas by Application (2021–2032)
Figure 56. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2032)
Figure 57. OPO-containing Infant Formulas Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232